{"transactions":[{"id":1028981,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":74728,"kind":"person","name":"Sweiti Hussein","position":1,"cik":"0002088436","reported_name":"Sweiti Hussein","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-01T20:54:55.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Non-qualified stock option grant awarded as an inducement award outside of the Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4). This option vests at 25% on September 29, 2026, which is the first anniversary of the employment commencement date, with the remaining portion to vest monthly over the remaining three years, subject to the reporting person's continued service."}],"balance_after":600000,"derivative":{"exercise_price":6.83,"expiration_date":"2035-09-30","underlying":"Common Shares","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000929638-25-003710","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1980845/000092963825003710/form4.xml","form_type":"4"}}]}